These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

585 related articles for article (PubMed ID: 23484720)

  • 21. [Changes of natural kill cell in peripheral blood of patients with myelodysplastic syndrome].
    Mi H; Fu R; Wang H; Qu W; Ruan E; Wang X; Wang G; Liu H; Wu Y; Song J; Xing L; Guan J; Li L; Jiang H; Zhang W; Yue L; Shao Z
    Zhonghua Yi Xue Za Zhi; 2014 Mar; 94(10):737-41. PubMed ID: 24844955
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transformation of myelodysplastic syndromes into acute myeloid leukemias.
    Shi J; Shao ZH; Liu H; Bai J; Cao YR; He GS; Tu MF; Wang XL; Hao YS; Yang TY; Yang CL
    Chin Med J (Engl); 2004 Jul; 117(7):963-7. PubMed ID: 15265365
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Imbalance between apoptosis and telomerase activity in myelodysplastic syndromes: possible role in ineffective hemopoiesis.
    Ohshima K; Karube K; Shimazaki K; Kamma H; Suzumiya J; Hamasaki M; Kikuchi M
    Leuk Lymphoma; 2003 Aug; 44(8):1339-46. PubMed ID: 12952227
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Expression of Fas, FasL and Bcl-2 and apoptosis of bone marrow CD34+ cells in patients with myelodysplastic syndrome].
    Zhang Z; Xie J
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Jun; 11(3):274-7. PubMed ID: 12844412
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of the distribution and clonal expansion features of the T-cell γδ repertoire in myelodysplastic syndrome-RAEB and RAEB with progression to AML.
    Geng S; Weng J; Du X; Lai P; Huang X; Chen S; Yang L; Li Y
    DNA Cell Biol; 2012 Oct; 31(10):1563-70. PubMed ID: 22873198
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CD8+HLA-DR+ T cells are increased in patients with severe aplastic anemia.
    Xing L; Liu C; Fu R; Wang H; Wang J; Liu X; Feng L; Li L; Liu H; Wang H; Zhang T; Shao Z
    Mol Med Rep; 2014 Sep; 10(3):1252-8. PubMed ID: 24969051
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Deviation of type I and type II T cells and its negative effect on hematopoiesis in myelodysplastic syndrome.
    Wu L; Li X; Chang C; Ying S; He Q; Pu Q
    Int J Lab Hematol; 2008 Oct; 30(5):390-9. PubMed ID: 19046314
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Analysis of immunophenotypic features of blasts in patients with myelodysplastic syndrome by flow cytometry and its diagnostic significance].
    Sun JF; Yang B; Zhang L; Huang Y; Yang J
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Jun; 20(3):632-5. PubMed ID: 22739171
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Peripheral blood lymphocyte subsets and their relation with early response to treatment in patients with low or intermediate risk myelodysplastic syndrome (IPSS score ≤ 1.0) and chronic aplastic anemia].
    Zhang MY; Ma J; Sun H; Xie XS; Wang C; Liu S; Li T
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Apr; 22(2):377-81. PubMed ID: 24763008
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical significance of regulatory T cells in patients with myelodysplastic syndrome.
    Hamdi W; Ogawara H; Handa H; Tsukamoto N; Nojima Y; Murakami H
    Eur J Haematol; 2009 Mar; 82(3):201-7. PubMed ID: 19018862
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Type I and type II T-cell profiles in aplastic anemia and refractory anemia.
    Tsuda H; Yamasaki H
    Am J Hematol; 2000 Aug; 64(4):271-4. PubMed ID: 10911379
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Study on the immunophenotype of myeloid cells in myelodysplastic syndromes and its clinical implications].
    Shao Z; Chen G; Lin Z; Zhang Y; Hao Y; Chu Y; Qian L; Yang T; Yang C; Feng B
    Zhonghua Xue Ye Xue Za Zhi; 1997 Feb; 18(2):80-3. PubMed ID: 15622783
    [TBL] [Abstract][Full Text] [Related]  

  • 33. More cell death in refractory anemia with excess blasts in transformation than in acute myeloid leukemia.
    Huh YO; Jilani I; Estey E; Giles F; Kantarjian H; Freireich E; Albitar M
    Leukemia; 2002 Nov; 16(11):2249-52. PubMed ID: 12399969
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effect of CD8+ effector T cells on the hematopoiesis pathway damage in the patients with severe aplastic anemia].
    Feng L; Fu R; Wang HQ; Wang J; Liu CY; Li LJ; Liu H; Wang HL; Zhang T; Ruan EB; Liang Y; Qu W; Wang GJ; Wu YH; Liu H; Wang XM; Song J; Guan J; Xing LM; Shao ZH
    Zhonghua Xue Ye Xue Za Zhi; 2011 Sep; 32(9):597-601. PubMed ID: 22338152
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Flow cytometric analysis of bone marrow cell cycles in patients with hematologic diseases].
    Meng FY; Ji H; Zhou Q
    Zhonghua Nei Ke Za Zhi; 1992 May; 31(5):297-9, 318. PubMed ID: 1478130
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Profiling three-dimensional nuclear telomeric architecture of myelodysplastic syndromes and acute myeloid leukemia defines patient subgroups.
    Gadji M; Adebayo Awe J; Rodrigues P; Kumar R; Houston DS; Klewes L; Dièye TN; Rego EM; Passetto RF; de Oliveira FM; Mai S
    Clin Cancer Res; 2012 Jun; 18(12):3293-304. PubMed ID: 22539801
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Detection of peripheral blood Th1/Th2 and Tc1/Tc2 subsets in patients with condyloma acuminatum and its significance].
    Zhu N; Cheng H; Zhu KJ; Zhang X; Xu Y; Jiang DH
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2009 Jun; 23(3):229-31. PubMed ID: 20104787
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quality of T-cells after stimulation with leukemia-derived dendritic cells (DC) from patients with acute myeloid leukemia (AML) or myeloid dysplastic syndrome (MDS) is predictive for their leukemia cytotoxic potential.
    Liepert A; Grabrucker C; Kremser A; Dreyssig J; Ansprenger C; Freudenreich M; Kroell T; Reibke R; Tischer J; Schweiger C; Schmid C; Kolb HJ; Schmetzer H
    Cell Immunol; 2010; 265(1):23-30. PubMed ID: 20663492
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased cytotoxic T cells with effector phenotype in aplastic anemia and myelodysplasia.
    Kook H; Zeng W; Guibin C; Kirby M; Young NS; Maciejewski JP
    Exp Hematol; 2001 Nov; 29(11):1270-7. PubMed ID: 11698122
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Flow cytometric evaluation of circulating CD34+ cell counts and apoptotic rate in children with acquired aplastic anemia and myelodysplasia.
    Timeus F; Crescenzio N; Doria A; Foglia L; Linari A; Giaccone M; Pastore G; di Montezemolo LC; Ramenghi U; Saracco P
    Exp Hematol; 2005 May; 33(5):597-604. PubMed ID: 15850838
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.